Prostate Imaging Using MRI +/- Contrast Enhancement (PRIME)
A Study Comparing Bi-parametric MRI to Multi-parametric MRI in the Diagnosis of Clinically Significant Prostate Cancer
Sponsor: University College, London
Listed as NCT04571840, this NA trial focuses on Prostate Cancer and remains ongoing. Sponsored by University College, London, it has been updated 9 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Oct 2024 — Present [monthly]
Active Not Recruiting NA
Status: Unknown → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Feb 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University College, London
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bordeaux, France , Buenos Aires, Argentina , Cambridge, United Kingdom , Copenhagen, Denmark , Córdoba, Spain , Düsseldorf, Germany , Essen, Germany , Frankfurt, Germany , Ghent, Belgium , Hamburg, Germany and 17 more locations